Pathophysiology of cardiorenal syndrome in decompensated heart failure: Role of lung-right heart-kidney interaction

M. Guazzi, P. Gatto, G. Giusti, F. Pizzamiglio, I. Previtali, C. Vignati, R. Arena

Research output: Contribution to journalArticle

Abstract

Cardiorenal syndrome (CRS) is defined as an interaction of cardiac disease with renal dysfunction that leads to diuretic resistance and renal function worsening, mainly with heart failure (HF) exacerbation. Hemodynamic variables linking heart and kidney are renal blood flow (cardiac output) and perfusion pressure, i.e., the aortic - renal venous pressure gradient. CRS has traditionally been interpreted as related to defective renal perfusion and arterial underfilling and, more recently, to elevation in central venous pressure transmitted back to renal veins. Our suggestion is that in a setting where aortic pressure is generally low, due to heart dysfunction and to vasodrepressive therapy, the elevated central venous pressure (CVP) contributes to lower the renal perfusion pressure below the threshold of kidney autoregulation (≤ 80 mm Hg) and causes renal perfusion to become directly pressure dependent. This condition is associated with high neurohumoral activation and preglomerular vasoconstriction that may preserve pressure, but may decrease filtration fraction and glomerular filtration rate and enhance proximal tubular sodium absorption. Thus, congestion worsens and drives the vicious cycle of further sodium retention and HF exacerbation. Lowering CVP by targeting the lung-right heart interaction that sustains elevated CVP seems to be a more rational approach rather than reducing intravascular volume. This interaction is crucial and consists of a cascade with stepwise development of pulmonary post-capillary hypertension, precapillary arteriolar hypertone, right ventricular overload and enlargement with tricuspid incompetence and interference with left ventricular filling (interdependence). The resultant CVP rise is transmitted to the renal veins, eventually drives CRS and leads to a positive feedback loop evolving towards HF refractoriness.

Original languageEnglish
Pages (from-to)379-384
Number of pages6
JournalInternational Journal of Cardiology
Volume169
Issue number6
DOIs
Publication statusPublished - Nov 30 2013

Fingerprint

Cardio-Renal Syndrome
Heart Failure
Central Venous Pressure
Kidney
Lung
Perfusion
Renal Veins
Pressure
Arterial Pressure
Sodium
Tricuspid Valve Insufficiency
Venous Pressure
Renal Circulation
Vasoconstriction
Glomerular Filtration Rate
Diuretics
Cardiac Output
Heart Diseases
Homeostasis
Hemodynamics

Keywords

  • Cardiorenal syndrome
  • Pulmonary hypertension
  • Right heart
  • Ultrafiltration

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Pathophysiology of cardiorenal syndrome in decompensated heart failure : Role of lung-right heart-kidney interaction. / Guazzi, M.; Gatto, P.; Giusti, G.; Pizzamiglio, F.; Previtali, I.; Vignati, C.; Arena, R.

In: International Journal of Cardiology, Vol. 169, No. 6, 30.11.2013, p. 379-384.

Research output: Contribution to journalArticle

Guazzi, M. ; Gatto, P. ; Giusti, G. ; Pizzamiglio, F. ; Previtali, I. ; Vignati, C. ; Arena, R. / Pathophysiology of cardiorenal syndrome in decompensated heart failure : Role of lung-right heart-kidney interaction. In: International Journal of Cardiology. 2013 ; Vol. 169, No. 6. pp. 379-384.
@article{552e64dd81f94eeea0342e8c7b4abd0e,
title = "Pathophysiology of cardiorenal syndrome in decompensated heart failure: Role of lung-right heart-kidney interaction",
abstract = "Cardiorenal syndrome (CRS) is defined as an interaction of cardiac disease with renal dysfunction that leads to diuretic resistance and renal function worsening, mainly with heart failure (HF) exacerbation. Hemodynamic variables linking heart and kidney are renal blood flow (cardiac output) and perfusion pressure, i.e., the aortic - renal venous pressure gradient. CRS has traditionally been interpreted as related to defective renal perfusion and arterial underfilling and, more recently, to elevation in central venous pressure transmitted back to renal veins. Our suggestion is that in a setting where aortic pressure is generally low, due to heart dysfunction and to vasodrepressive therapy, the elevated central venous pressure (CVP) contributes to lower the renal perfusion pressure below the threshold of kidney autoregulation (≤ 80 mm Hg) and causes renal perfusion to become directly pressure dependent. This condition is associated with high neurohumoral activation and preglomerular vasoconstriction that may preserve pressure, but may decrease filtration fraction and glomerular filtration rate and enhance proximal tubular sodium absorption. Thus, congestion worsens and drives the vicious cycle of further sodium retention and HF exacerbation. Lowering CVP by targeting the lung-right heart interaction that sustains elevated CVP seems to be a more rational approach rather than reducing intravascular volume. This interaction is crucial and consists of a cascade with stepwise development of pulmonary post-capillary hypertension, precapillary arteriolar hypertone, right ventricular overload and enlargement with tricuspid incompetence and interference with left ventricular filling (interdependence). The resultant CVP rise is transmitted to the renal veins, eventually drives CRS and leads to a positive feedback loop evolving towards HF refractoriness.",
keywords = "Cardiorenal syndrome, Pulmonary hypertension, Right heart, Ultrafiltration",
author = "M. Guazzi and P. Gatto and G. Giusti and F. Pizzamiglio and I. Previtali and C. Vignati and R. Arena",
year = "2013",
month = "11",
day = "30",
doi = "10.1016/j.ijcard.2013.09.014",
language = "English",
volume = "169",
pages = "379--384",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",
number = "6",

}

TY - JOUR

T1 - Pathophysiology of cardiorenal syndrome in decompensated heart failure

T2 - Role of lung-right heart-kidney interaction

AU - Guazzi, M.

AU - Gatto, P.

AU - Giusti, G.

AU - Pizzamiglio, F.

AU - Previtali, I.

AU - Vignati, C.

AU - Arena, R.

PY - 2013/11/30

Y1 - 2013/11/30

N2 - Cardiorenal syndrome (CRS) is defined as an interaction of cardiac disease with renal dysfunction that leads to diuretic resistance and renal function worsening, mainly with heart failure (HF) exacerbation. Hemodynamic variables linking heart and kidney are renal blood flow (cardiac output) and perfusion pressure, i.e., the aortic - renal venous pressure gradient. CRS has traditionally been interpreted as related to defective renal perfusion and arterial underfilling and, more recently, to elevation in central venous pressure transmitted back to renal veins. Our suggestion is that in a setting where aortic pressure is generally low, due to heart dysfunction and to vasodrepressive therapy, the elevated central venous pressure (CVP) contributes to lower the renal perfusion pressure below the threshold of kidney autoregulation (≤ 80 mm Hg) and causes renal perfusion to become directly pressure dependent. This condition is associated with high neurohumoral activation and preglomerular vasoconstriction that may preserve pressure, but may decrease filtration fraction and glomerular filtration rate and enhance proximal tubular sodium absorption. Thus, congestion worsens and drives the vicious cycle of further sodium retention and HF exacerbation. Lowering CVP by targeting the lung-right heart interaction that sustains elevated CVP seems to be a more rational approach rather than reducing intravascular volume. This interaction is crucial and consists of a cascade with stepwise development of pulmonary post-capillary hypertension, precapillary arteriolar hypertone, right ventricular overload and enlargement with tricuspid incompetence and interference with left ventricular filling (interdependence). The resultant CVP rise is transmitted to the renal veins, eventually drives CRS and leads to a positive feedback loop evolving towards HF refractoriness.

AB - Cardiorenal syndrome (CRS) is defined as an interaction of cardiac disease with renal dysfunction that leads to diuretic resistance and renal function worsening, mainly with heart failure (HF) exacerbation. Hemodynamic variables linking heart and kidney are renal blood flow (cardiac output) and perfusion pressure, i.e., the aortic - renal venous pressure gradient. CRS has traditionally been interpreted as related to defective renal perfusion and arterial underfilling and, more recently, to elevation in central venous pressure transmitted back to renal veins. Our suggestion is that in a setting where aortic pressure is generally low, due to heart dysfunction and to vasodrepressive therapy, the elevated central venous pressure (CVP) contributes to lower the renal perfusion pressure below the threshold of kidney autoregulation (≤ 80 mm Hg) and causes renal perfusion to become directly pressure dependent. This condition is associated with high neurohumoral activation and preglomerular vasoconstriction that may preserve pressure, but may decrease filtration fraction and glomerular filtration rate and enhance proximal tubular sodium absorption. Thus, congestion worsens and drives the vicious cycle of further sodium retention and HF exacerbation. Lowering CVP by targeting the lung-right heart interaction that sustains elevated CVP seems to be a more rational approach rather than reducing intravascular volume. This interaction is crucial and consists of a cascade with stepwise development of pulmonary post-capillary hypertension, precapillary arteriolar hypertone, right ventricular overload and enlargement with tricuspid incompetence and interference with left ventricular filling (interdependence). The resultant CVP rise is transmitted to the renal veins, eventually drives CRS and leads to a positive feedback loop evolving towards HF refractoriness.

KW - Cardiorenal syndrome

KW - Pulmonary hypertension

KW - Right heart

KW - Ultrafiltration

UR - http://www.scopus.com/inward/record.url?scp=84888006622&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888006622&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2013.09.014

DO - 10.1016/j.ijcard.2013.09.014

M3 - Article

C2 - 24182905

AN - SCOPUS:84888006622

VL - 169

SP - 379

EP - 384

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

IS - 6

ER -